GLP Success vs GLP Winner.
GLP Winner positions itself as an independent comparison site for GLP-1 telehealth. Their own published documents describe a different product: a paid lead-generation marketplace where every listed clinic is a contracted partner. We respect that they publish the terms; most affiliate sites don't. But the comparison resource their homepage advertises and the marketplace they actually run are not the same product.
Per GLP Winner's own partnership terms, the only described path to being listed is accepting a paid services agreement. The result set you see on their site is, structurally, 100% paid placements.
The same site, read twice
Every card below has two faces, both verbatim and both sourced: what GLP Winner publicly says about itself, and what its own contracts and editorial behavior establish. Flip them yourself.
“Comparison resource for real people. We don't sell this — we help people compare options.”
“We provide the Platform as a passive conduit for listing Products. All Leads independently select Products based on their own discretion.”
Partnership Terms §1(o)
“We strive to ensure that such financial relationships do not affect the order in which providers are displayed and maintain our commitment to providing unbiased information.”
Site-wide footer
“These reviews are not sponsored. [Brand name] is one of many companies partnered with my company and, if you choose them as your provider, GLP Winner may receive compensation, but I'm not writing this to make you upgrade with them.”
Sabina Hemmi, GLP Winner founder, in published clinic reviews
“Don't Lie. Honor the policies you state in your marketing and terms. No false or misleading information given to GLP Winner's team or patients about your products, services, prices, or treatments.”
Code of Conduct
Follow the money
How GLP Winner gets paid
How GLP Success doesn't
At a glance
| Dimension | GLP Winner | GLP Success |
|---|---|---|
| Accepts payment from listed clinics | Yes: paid lead-generation marketplace per published terms | No |
| Where the partnership terms are linked from | Nowhere. The terms exist at /resources/partnership-terms but are not linked from the homepage, footer, or main nav. Reachable only via direct URL or via the site's sitemap.xml. | Disclosure banner on every page; "How we make money" is one click from any route. |
| Displays affiliate coupon codes inline | Yes: partners contractually obligated to provide their lowest public coupon | No |
| Methodology | User-survey preferences + 3 quality labels (Patient Loved, Cheapest, Popular) | Two binary gates, pharmacy + clinic. Both must pass. |
| Public exclusion list with sourced reasons | No | Yes |
| Reviews non-paying clinics | No: reviewed clinics are exclusively paying partners | Yes: any clinic, partnership status not applicable |
| FDA enforcement actions visible on pharmacy profile | No: only surfaced in AI-generated summaries, not structured data | Yes: every pharmacy profile has a regulatory record block |
| Allows Internet Archive crawler | No: Vercel WAF blocks the IA crawler. "Save Page Now" requests fail. Two pre-WAF historical snapshots remain accessible. | Yes: robots.txt explicitly invites archive.org |
| MFN clause on partner pricing | Yes: partners must give GLP Winner the lowest public coupon within 2 business days of any change | Not applicable: no partnerships |
| Editorial firewall published | No: Code of Conduct is partner-facing only | Yes: see /methodology and /how-we-make-money |
Why this matters: the Casa case
Take Orderly Meds. Orderly is listed on GLP Winner under the same partnership terms as every other clinic on the platform. On its own FAQ page, Orderly states verbatim: “We currently partner with PerfectRx/PerfectionRx, ProRx, Casa, Pharmacy Hub and SmartPharmaRx.” Casa is Casa Pharma Rx, a 503A based in Stafford, Texas. Casa ships compounded GLP-1 prescriptions into roughly 24 states but is verifiably licensed in only a fraction of them. The gap is publicly documentable — and you can explore it yourself on the map below, state board by state board.
From our verified state-board sweeps — the same records on Casa Pharma Rx's pharmacy file.
This is not buried knowledge. Anyone in the GLP-1 telehealth industry can run the same lookups in thirty minutes. GLP Winner's founder, who personally writes the platform's editorial reviews, can run them too. So the question is not whether she could know. The question is why a self-described “comparison resource for real people” does not surface the licensing gap on the profile of a clinic shipping medication through an unlicensed pharmacy into states where the patient lives.
The structural answer is in her own partnership terms. Orderly is a paying partner. GLP Winner is paid when Orderly converts. Surfacing the Casa licensing gap would cost Orderly conversions, which would cost GLP Winner revenue, which would put the partnership in tension with the editorial product. The platform's structural incentive is to not look too hard at partners who are paying.
That is the pattern the site cannot escape:
- You cannot use GLP Winner to find a clinic that refused to pay them. Such clinics simply do not appear. Their absence is invisible. You cannot tell from the site whether a missing brand is missing because of quality concerns, because it refused to share authoritative tracking, because it refused to surrender its lowest coupon code under the MFN clause, or because it chose to spend its marketing dollars elsewhere. The site does not distinguish.
- The criticism that does get published is internal to the partner roster. When a review calls a partner's onboarding forms “clunky,” the same article credits the partner with having “since updated” the experience. That is the only kind of criticism the structure permits.
- Bad actors who pay get reviewed kindly. Bad actors who don't pay get reviewed not at all. Trava, a non-partner with documented warm-vial shipping problems and customer-service issues from mid-2025, has no review on the platform. The Casa licensing gap is in no /insights/ piece. The pool of “things the platform notices in print” is the partner pool, screened for partner-favorability.
GLP Winner is not unethical for running this business. It is, however, fundamentally a paid placement platform that does not flag the licensing or quality concerns of paying partners. Calling it a “comparison resource” understates the role of payment in deciding what gets compared, and what doesn't.
Where GLP Winner's pricing might mislead
Their partnership terms include an MFN-style clause obligating partners to give them the lowest publicly available coupon code. So the inline coupon you see on GLP Winner is contractually at least as cheap as anything else publicly out there. But Reddit-thread codes, private referral codes, and quietly-negotiated rates routinely undercut it. We wrote a longer piece about this: Why GLP Winner's price isn't the cheapest legit price →
The contract, clause by clause
These clauses come verbatim from GLP Winner's Partnership Terms and Conditions as captured on May 9, 2026. The page is not linked from glpwinner.com's homepage, footer, or main navigation — it's reachable only via direct URL or the site's sitemap. The Wayback Machine has two historical captures (Dec 2025 and Mar 2026) whose digests differ, meaning the document was materially edited between those dates, even though the displayed “Last updated” date on the live page reads November 25, 2025. Open any clause below.
§1(c)Listing follows acceptance of the paid agreement
“We will list Products on our Platform within two (2) business days from the date you accept these Terms (the "Effective Date"), provided you submit all required information and materials requested by us.”
§1(b)No path to promotion outside the agreement
“We have no obligation to promote any other products, services, or you under these Terms of Service.”
§1(k)MFN coupon clause
“You must ensure that we receive a coupon code that reflects the lowest price or highest publicly available discount you offer on the applicable product(s) at any given time, including any codes made available through public promotions, advertisements, or your website.”
§1(j)2-day price-change notice
“You must use commercially reasonable efforts to provide us with the most current pricing of any product and must notify us of any change in price no later than two business days after such change.”
§2(a)GLP Winner's own tracking is contractually authoritative for billing
“Our Reports are authoritative and binding for all purposes under these Terms, including billing and payment. All billing and payment obligations are based solely and exclusively on our tracking and our Reports.”
§2(b)Third-party tracking is presumed wrong
“We assume third-party tracking is incomplete and inaccurate until you provide commercially reasonable evidence proving otherwise, in a form and substance satisfactory to us in our sole discretion.”
§5Partner cannot use another comparison platform
“We are your exclusive provider of marketing services with respect to sales of the Products to Leads through a software marketplace platform during the Term.”
§8(a)GLP Winner can terminate for any reason
“Notwithstanding the foregoing, GLP Winner may terminate these Terms for any reason or no reason upon thirty (30) days' prior written notice to Company.”
§1(o)Self-described “passive conduit”
“We do not direct, endorse, or steer potential Leads to your or any other party’s Products or website. You acknowledge that we provide the Platform as a passive conduit for listing Products. All Leads independently select Products based on their own discretion.”
We keep a verbatim local archive of this document so we can flag any material changes. If the live page is removed or the displayed “Last updated” date is moved without an actual content edit, we will publish a comparison against our baseline.
What we don't do better
GLP Winner's pharmacy treatment is genuinely good: they catalogue compounders as first-class entities, with profile pages and additive disclosures. We've aimed to match that and add structured FDA enforcement records their pharmacy pages don't surface.
GLP Winner aggregates user reviews from Trustpilot, Google, and their own community across 100+ providers. We don't aggregate user reviews; we don't consider star counts a reliable signal of long-term clinical quality. If patient star ratings matter to you, they have more of them with broader provider coverage.
GLP Winner publishes new editorial content several times a week. We publish rarely, only when there's a structural story to tell.
Why GLP Success isn't this
GLP Success accepts no payment from any clinic listed. There is no partnership terms page on this site because there are no partnerships to govern. No clinic has paid us, threatened us, or asked us to soften coverage. None could.
Our list is built from two binary gates, pharmacy quality and clinic quality, both published in full at /methodology. Clinics that pass are listed. Clinics that fail are on the Do Not Buy list with sourced reasons. The exclusion list is the most important page on this site, because it is the page a paid platform structurally cannot publish.
Is GLP Winner legit? Common questions
Is GLP Winner legit?
GLP Winner is a real, operating company. The question most people mean is whether it is independent. Per GLP Winner's own published Partnership Terms, it is a paid lead-generation marketplace: the only described path to being listed is a paid services agreement, so every clinic shown is a contracted partner.
Is GLP Winner independent?
Not in the way its homepage implies. GLP Winner's own Partnership Terms describe paid placement. Clinics that do not pay are not listed, and the licensing or quality concerns of paying partners are not surfaced. The result set is, structurally, paid placements.
How does GLP Winner make money?
GLP Winner is paid by the clinics it lists, on a per-conversion basis, under its Partnership Terms. It is an affiliate and lead-generation marketplace, not a fee-free editorial comparison.
What is the best alternative to GLP Winner?
GLP Success is an independent alternative. We accept no payment from any clinic or pharmacy we cover, we name the compounding pharmacy behind each clinic, we check its licensing and FDA record, and we publish the ones that fail on the Do Not Buy list.
Spotted a claim above that GLP Winner has since changed? Email editorial@glpsuccess.org. We update with a public changelog entry.